Vice President, Late Stage Ophthalmology - DME
4D Molecular Therapeutics
About this role
The VP, Late Stage Ophthalmology at 4DMT is a senior physician leadership role within Drug Development focused on advancing late-stage ophthalmic genetic medicine programs. The role is part of the executive medical leadership reporting to the Chief Medical Officer and supports the company’s retinal and ocular therapeutic candidates as they progress toward regulatory submission and approval.
Skills
Qualifications
About 4D Molecular Therapeutics
4dmoleculartherapeutics.com4D Molecular Therapeutics (4DMT) is a clinical-stage biotechnology company that designs, develops, and commercializes gene therapies for serious, unmet medical conditions. Using a proprietary AAV capsid engineering and targeted delivery platform, 4DMT creates vectors optimized for tissue specificity, potency, and manufacturability to improve safety and therapeutic benefit. The company focuses on translational programs across ocular, neuromuscular, central nervous system, and cardiopulmonary indications and partners to advance candidates toward clinical and commercial development.
Recent company news
Yahoo FinanceWhere is 4D Molecular Therapeutics (FDMT) Headed According to the Street?
2 weeks ago
TradingViewFDMT: Rapid phase 3 progress and strong market interest position 4D-150 for global commercialization
2 days ago
MarketBeat4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Rating of "Moderate Buy" by Brokerages
1 week ago
Stock TitanBiotech 4DMT heads to three March healthcare investor conferences
3 weeks ago
Seeking Alpha4D Molecular Therapeutics: This Gene Therapy Company May Soon Surprise Investors (NASDAQ:FDMT)
Sep 30, 2025
About 4D Molecular Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for 4D Molecular Therapeutics.
Salary
$350k – $440k
per year
More jobs at 4D Molecular Therapeutics
Similar Jobs
Vice President, Late-Stage Oncology Clinical Operations
American Association of Physicists in Medicine
Sr. Scientist, Stat. Programming - Late Stage (Hybrid)
MSD
Vice President, Medical Affairs
Alkeus Pharmaceuticals
Senior Associate Scientist, Retinal Degeneration
Sanofi
Medical Director - Ophthalmology
Parexel
Medical Director - Ophthalmology
Parexel